Overview: Jalra-DP Tablet SR is an oral combination medicine used to control high blood sugar levels in type 2 diabetes mellitus. It contains Dapagliflozin (10mg) and Vildagliptin (100mg). This dual-action formulation improves glycemic control by targeting multiple mechanisms. Key Benefits: – Helps reduce blood glucose effectively – Promotes weight reduction and blood pressure control – Minimizes risk of hypoglycemia Composition: Dapagliflozin (10mg) + Vildagliptin (100mg) How It Works: Dapagliflozin works by removing excess sugar through urine (SGLT2 inhibition), while Vildagliptin increases insulin secretion and reduces glucose production by inhibiting DPP-4 enzymes. Usage Instructions: – Take as directed by your doctor, usually once daily – Swallow whole with water, with or without food – Regular monitoring of blood glucose levels is advised Side Effects: – Urinary tract infection – Headache – Hypoglycemia (low blood sugar) – Dizziness – Increased urination Precautions: – Not recommended in patients with severe kidney disease – Stay hydrated to prevent dehydration – Use with caution in elderly patients Storage Instructions: – Store below 30°C – Keep away from moisture and direct sunlight Manufacturer: USV Ltd Disclaimer: Use under medical supervision. This is a prescription medicine.